Loading…
In Vitro and In Vivo Studies for the Investigation of γ-Globin Gene Induction by Adhatoda vasica : A Pre-Clinical Study of HbF Inducers for β-Thalassemia
Fetal hemoglobin (HbF) is a potent genetic modifier, and the γ-globin gene induction has proven to be a sustainable therapeutic approach for the management of β-thalassemia. In this study, we have evaluated the HbF induction ability of and , and the identification of potential therapeutic compounds...
Saved in:
Published in: | Frontiers in pharmacology 2022-03, Vol.13, p.797853 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Fetal hemoglobin (HbF) is a potent genetic modifier, and the γ-globin gene induction has proven to be a sustainable therapeutic approach for the management of β-thalassemia. In this study, we have evaluated the HbF induction ability of
and
, and the identification of potential therapeutic compounds through a bioassay-guided approach.
benzidine-Hb assay demonstrated strong erythroid differentiation of K562 cells by
extracts. Subsequently, an
study with an aqueous extract of
(100 mg/kg) showed significant induction of the γ-globin gene and HbF production. While in the acute study, the hematological and biochemical indices were found to be unaltered at the lower dose of
. Following the bioassay-guided approach, two isolated compounds, vasicinol (
) and vasicine (
) strongly enhanced HbF levels and showed prominent cellular growth kinetics with ample accumulation of total hemoglobin in K562 cultures. High HbF levels were examined by immunofluorescence and flow cytometry analysis, concomitant with the overexpression in the γ-globin gene level. Compound
(0.1 µM) and compound
(1 µM) resulted in a greater increase in F-cells (90 and 83%) with marked up (8-fold and 5.1-fold) expression of the γ-globin gene, respectively. Molecular docking studies indicated strong binding affinities of (
) and (
) with HDAC2 and KDM1 protein that predict the possible mechanism of compounds in inhibition of these epigenetic regulators in the γ-globin gene reactivation. Altogether, these observations demonstrated the therapeutic usefulness of
for fostering HbF production in clinical implications for blood disorders. |
---|---|
ISSN: | 1663-9812 1663-9812 |
DOI: | 10.3389/fphar.2022.797853 |